Literature DB >> 15489506

Substitution of conserved residues within the active site alters the cleavage religation equilibrium of DNA topoisomerase I.

William C Colley1, Marie van der Merwe, John R Vance, Alex B Burgin, Mary-Ann Bjornsti.   

Abstract

Eukaryotic DNA topoisomerase I (Top1p) catalyzes the relaxation of supercoiled DNA and constitutes the cellular target of camptothecin (CPT). Mutation of conserved residues in close proximity to the active site tyrosine (Tyr(727) of yeast Top1p) alters the DNA cleavage religation equilibrium, inducing drug-independent cell lethality. Previous studies indicates that yeast Top1T722Ap and Top1N726Hp cytotoxicity results from elevated levels of covalent enzyme-DNA intermediates. Here we show that Top1T722Ap acts as a CPT mimetic by exhibiting reduced rates of DNA religation, whereas increased Top1N726Hp.DNA complexes result from elevated DNA binding and cleavage. We also report that the combination of the T722A and N726H mutations in a single protein potentiates the cytotoxic action of the enzyme beyond that induced by co-expression of the single mutants. Moreover, the addition of CPT to cells expressing the double top1T722A/N726H mutant did not enhance cell lethality. Thus, independent alterations in DNA cleavage and religation contribute to the lethal phenotype. The formation of distinct cytotoxic lesions was also evidenced by the different responses induced by low levels of these self-poisoning enzymes in isogenic strains defective for the Rad9 DNA damage checkpoint, processive DNA replication, or ubiquitin-mediated proteolysis. Substitution of Asn(726) with Phe or Tyr also produces self-poisoning enzymes, implicating stacking interactions in the increased kinetics of DNA cleavage by Top1N726Hp and Top1N726Fp. In contrast, replacing the amide side chain of Asn(726) with Gln renders Top1N726Qp resistant to CPT, suggesting that the orientation of the amide within the active site is critical for effective CPT binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489506     DOI: 10.1074/jbc.M409764200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Mapping topoisomerase sites in mitochondrial DNA with a poisonous mitochondrial topoisomerase I (Top1mt).

Authors:  Ilaria Dalla Rosa; Shar-Yin N Huang; Keli Agama; Salim Khiati; Hongliang Zhang; Yves Pommier
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

2.  DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.

Authors:  Christine M Wright; Marié van der Merwe; Amanda H DeBrot; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

3.  Tyrosyl-DNA phosphodiesterase I catalytic mutants reveal an alternative nucleophile that can catalyze substrate cleavage.

Authors:  Evan Q Comeaux; Selma M Cuya; Kyoko Kojima; Nauzanene Jafari; Keith C Wanzeck; James A Mobley; Mary-Ann Bjornsti; Robert C A M van Waardenburg
Journal:  J Biol Chem       Date:  2015-01-21       Impact factor: 5.157

4.  Biochemical analysis of phenotypic diversity associated with mutations in codon 244 of the retinal degeneration slow gene.

Authors:  Shannon M Conley; Heidi M Stricker; Muna I Naash
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

5.  Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the N terminus in clamp closure.

Authors:  Komaraiah Palle; Luca Pattarello; Marié van der Merwe; Carmen Losasso; Piero Benedetti; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2008-08-08       Impact factor: 5.157

6.  Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin.

Authors:  Marié van der Merwe; Mary-Ann Bjornsti
Journal:  J Biol Chem       Date:  2007-12-04       Impact factor: 5.157

7.  Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study.

Authors:  Giovanni Chillemi; Paola Fiorani; Silvia Castelli; Alessandro Bruselles; Piero Benedetti; Alessandro Desideri
Journal:  Nucleic Acids Res       Date:  2005-06-08       Impact factor: 16.971

8.  Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I.

Authors:  Zhaoqi Yang; Tuoyu Jiang; Hanshi Zhong; Yu Kang
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

9.  Deletions associated with stabilization of the Top1 cleavage complex in yeast are products of the nonhomologous end-joining pathway.

Authors:  Jang-Eun Cho; Sue Jinks-Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-21       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.